As the larger cohort consisted primarily of patients categorized into the tauopathy FTD subgroup, it is possible that both our cohort and the 17-eye cohort represented more patients with TDP-43 proteinopathy, which may explain the observed differences in results. The gene discussed is TARDBP; the disease is proteostasis deficiencies.